Women’s acceptability of HPV self-collection in a healthcare setting following FDA approval in the United States
The United States Food and Drug Administration approved human papillomavirus (HPV) self-collection in a healthcare setting as a cervical cancer screening approach in May 2024. It is therefore important to examine women's acceptability of this approach. We conducted an online survey in September 2024 with a national sample of women ages 45-65 from the United States (